Results for tag: "Immunocytokine"

Immunocytokines are a type of immune disorder drug that combines the targeting capabilities of monoclonal antibodies with the immunomodulatory properties of cytokines. They are designed to target and activate specific immune cells, such as T cells, to induce an immune response against a particular antigen. Immunocytokines are used to treat a variety of immune-related diseases, including cancer, autoimmune diseases, and infectious diseases. They are also being investigated for their potential to treat allergies and other immune-related conditions. Immunocytokines are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies. They are generally well-tolerated and have few side effects. The immunocytokine market is growing rapidly, driven by increasing demand for treatments for immune-related diseases. The market is expected to continue to grow in the coming years, as new treatments are developed and approved. Some companies in the immunocytokine market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more